L. Hou et al., PROTEASE-ACTIVATED RECEPTORS AND THEIR ROLE IN IL-6 AND NF-IL-6 EXPRESSION IN HUMAN GINGIVAL FIBROBLASTS, Journal of periodontal research, 33(4), 1998, pp. 205-211
The serine protease thrombin is formed at sites of coagulation and inf
lammation and has been shown to have important proinflammatory cellula
r effects relevant to the pathogenesis of periodontal disease. Thrombi
n acts via specific cell surface receptors termed protease-activated r
eceptor-1 (PAR-1) and PAR-3, which have a distinctive method of activa
tion. Proteolytic cleavage of the extracellular domain by thrombin rev
eals a hidden amino terminus which then acts as a ''tethered ligand''.
A short synthetic peptide (SFLLRN) can also mimic the tethered ligand
and activate PAR-1 but not PAR-3. Also, a trypsin-sensitive receptor
termed PAR-2 has been described which is activated by the PAR-1 activa
ting peptide SFLLRN. Here we show conclusively by flow cytometric and
Northern blot analysis that human gingival fibroblasts (HGF) express P
AR-1 bur not PAR-2. In functional studies we also show that thrombin a
nd SFLLRN stimulated increased expression of mRNA encoding nuclear tra
nscription factor NF-IL-6 and IL-6 in vitro. At optimal concentrations
, thrombin (10(-7) M) induced 7.6 +/- 0.01 ng/ml immunoactive IL-6 and
PAR-1 activating peptide (5 x 10(-5) M) induced 2.2+/-0.2 ng/ml (mean
+/- standard error of mean). A proteolytically inactive recombinant t
hrombin (serine 195 to alanine) was without activity. These data show
that HGF express PAR-1 and suggest that PAR-1 activation stimulates in
creased NF-IL-6 and IL-6 gene expression and IL-6 secretion by HGF in
vitro. Whether HGF express PAR-3 is unknown, but the fact that SFLLRN
was not a complete replacement for thrombin raises the possibility tha
t HGF may express additional thrombin receptors. These findings add we
ight to the importance of the cytokine-like role played by thrombin an
d raise the possibility that protease-activated receptors may play a r
ole in the pathogenesis of inflammatory periodontal disease.